Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

SHE:300702 Revenue

Zhejiang Tianyu Pharmaceutical had revenue of 1.01B CNY in the quarter ending September 30, 2026, with 39.86% growth. This brings the company's total for the last twelve months to 3.58B, up 12.18% year-over-year. In the year 2025, Zhejiang Tianyu Pharmaceutical had annual revenue of 3.06B with 16.36% growth. That makes Zhejiang Tianyu Pharmaceutical the 10,880th largest company in the world by revenue and 1,813th in China.

• Revenue (ttm): 3.58B
• Revenue Growth: +12.18%
• P/S Ratio: 1.94
• Revenue / Employee: 764.60K
• Employees: 4,686
• Market Cap: 6.96B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Generic drug APIs and intermediates 2.22B 72.6%
• Preparations 418.00M 13.7%
• CDMO APIs and Intermediates 391.90M 12.8%
• other 29.36M 1.0%

By Geography

Chart

• Overseas 1.63B 53.2%
• China 1.43B 46.8%

Fiscal year ended Dec 31, 2025 See the full SHE:300702 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.06B	430.33M	16.36%
Dec 31, 2024	2.63B	103.54M	4.10%
Dec 31, 2023	2.53B	-139.41M	-5.23%
Jan 1, 2023	2.67B	121.67M	4.78%
Jan 1, 2022	2.55B	-42.39M	-1.64%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error